ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,067.00
-1.24%
S&P ASX All Technology
3,766.30
-0.74%
Brent Oil
72.245
-0.19%
US Dollar vs AUD
1.60268
-0.13%
Bitcoin
97,866.61
0.42%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Gilead Sciences Inc (GIS) Share Price

Gilead Sciences Inc

Gilead Sciences Inc (GIS)

Gismondi 1754 SpA
General Mills Inc
Genesis Metals Corp
87.50
-0.36
( -0.41% )
Updated: 18:35:48
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
87.50
Bid
87.34
Offer
87.66
Volume
242
87.32 Day's Range 87.50
57.18 52 Week Range 92.77
Market Cap
109.048B
Previous Close
87.86
Open
87.44
Last Trade
171
@
87.5
Last Trade Time
18:29:58
Financial Volume
-
VWAP
-
Average Volume (3m)
5,753
Shares Outstanding
1,246,265,857
Dividend Yield
3.65%
PE Ratio
20.04
Earnings Per Share (EPS)
4.55
Revenue
27.12B
Net Profit
5.67B

About Gilead Sciences Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.gilead.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Gilead Sciences Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker GIS. The last closing price for Gilead Sciences was 87.86 €. Over the last year, Gilead Sciences shares have traded in a share price range of 57.18 € to 92.77 €.

Gilead Sciences currently has 1,246,265,857 shares in issue. The market capitalisation of Gilead Sciences is 109.50 € billion. Gilead Sciences has a price to earnings ratio (PE ratio) of 20.04.

Ask ADVFN Intelligence (AI)

GIS Latest News

More News

Gilead and Genesis team up on using AI to develop novel therapeutics

Gilead Sciences Inc on Tuesday announced a strategic collaboration with Genesis Therapeutics Inc to discover and deve ...

11 September 2024
Alliance News

Gilead notes transfer of Yescarta marketing authorisation from Daiichi

Gilead Sciences Inc on Thursday said that the marketing authorisation in Japan for its chimeric antigen receptor T-ce ...

23 June 2023
Alliance News

GLOBAL BUSINESS: Bristol-Myers wins approval for Breyanzi in Japan

The following is a round-up of updates by global companies, issued on Tuesday and not separately reported by Alliance ...

21 December 2022
Alliance News

World Health Organisation 'strongly recommends' Pfizer's covid pill

The World Health Organization said Friday it "strongly recommended" Pfizer Inc's covid-19 antiviral pill Paxlovid for ...

22 April 2022
Alliance News

TOP NEWS: GSK's ViiV gets USD1.25 billion from Gilead patent pact

GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent in ...

02 February 2022
Alliance News

Gilead Sciences receives expedited approval for antiviral drug Veklury

Gilead Sciences Inc on Friday said that the US Food & Drug Administration granted its Veklury drug expedited approval ...

24 January 2022
Alliance News

Gilead and Merck & Co HIV double drug combo starts Phase 2 study

Gilead Sciences Inc and Merck & Co Inc announced Tuesday the start of a Phase 2 clinical study evaluating an investig ...

26 October 2021
Alliance News

Gilead Sciences Teams Up With Vir To Develop Chronic Hepatitis B Cure

Gilead Sciences Inc on Tuesday said it has entered into a clinical collaboration with Vir Biotechnology Inc focused o ...

13 January 2021
Alliance News

Gilead Sciences Ups Annual Guidance As Covid-19 Drug Boosts Sales

Gilead Sciences Inc on Monday said it has increased its product sales guidance for 2020 as one of its drugs used to t ...

11 January 2021
Alliance News

Gilead's Kite, Oxford BioTherapeutics Partner On Cell Therapy Research

Kite, a Gilead Sciences Inc portfolio company, on Wednesday said it and Oxford BioTherapeutics Ltd have entered into ...

07 January 2021
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.31-0.35303496184987.8189.0585.25339287.76786287DE
41.631.8982182368785.8790.4485.25541188.3140892DE
1213.0517.528542646174.4592.7773.92575384.96537379DE
2628.5148.330225461958.9992.7758.53518776.71805997DE
5215.1220.889748549372.3892.7757.18525572.07549966DE
15624.238.230647709363.392.7752.06441970.79793623DE
26029.0949.803115904858.4192.7746.1651076865.42179091DE

GIS - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences share price?
The current share price of Gilead Sciences is 87.50 €
How many Gilead Sciences shares are in issue?
Gilead Sciences has 1,246,265,857 shares in issue
What is the market cap of Gilead Sciences?
The market capitalisation of Gilead Sciences is EUR 109.5B
What is the 1 year trading range for Gilead Sciences share price?
Gilead Sciences has traded in the range of 57.18 € to 92.77 € during the past year
What is the PE ratio of Gilead Sciences?
The price to earnings ratio of Gilead Sciences is 20.04
What is the cash to sales ratio of Gilead Sciences?
The cash to sales ratio of Gilead Sciences is 4.19
What is the reporting currency for Gilead Sciences?
Gilead Sciences reports financial results in USD
What is the latest annual turnover for Gilead Sciences?
The latest annual turnover of Gilead Sciences is USD 27.12B
What is the latest annual profit for Gilead Sciences?
The latest annual profit of Gilead Sciences is USD 5.67B
What is the registered address of Gilead Sciences?
The registered address for Gilead Sciences is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Gilead Sciences website address?
The website address for Gilead Sciences is www.gilead.com
Which industry sector does Gilead Sciences operate in?
Gilead Sciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LTIAptose Biosciences Inc
0.398 €
(141.21%)
8k
3350Aadi Bioscience Inc
3.62 €
(61.61%)
8.23k
M5ZManz Automation Ag Npv
2.23 €
(25.63%)
256.17k
7D2ASedana Medical AB
1.60 €
(18.17%)
1.4k
UMDKUMT United Mobility Technology
0.30 €
(12.78%)
1,000
722Antengene Corporation Ltd
0.0525 €
(-32.26%)
4.5k
CNWCodon AG
0.0075 €
(-31.82%)
304
VOPInvestigator Resources Ltd
0.008 €
(-30.43%)
1.08k
47GAGo Metals Corp
0.0202 €
(-29.37%)
533
3PMInfinity Lithium Corporation Limited
0.0142 €
(-22.83%)
10k
AXIAtos SE
0.0022 €
(4.76%)
38.07M
D7GNel ASA
0.2481 €
(-2.09%)
500.98k
RQ0DWave Quantum Inc
5.42 €
(-12.13%)
258.91k
M5ZManz Automation Ag Npv
2.23 €
(25.63%)
256.17k
3CPXiaomi Corporation
3.9055 €
(2.98%)
160.04k

Discussion

View Full Feed
GASMASK GASMASK 16 minutes ago
What's/who's TA?
MRGE
JerryCampbell JerryCampbell 33 minutes ago
Data entry error the previous day.

Someone mistakenly entered 8,000,000 instead of 800,000. The -7.2m corrects it.
NWBO
georgejjl georgejjl 33 minutes ago
I guess that Anavex could have sales of $14 billion during the first full year after approval in 2026 by the EMA in the EU alone based on capturing a 25% market share of the 8 million people in the EU with Alzheimer’s disease at a prescription cost of $7,000 per year per patient.

Go
AVXL
jeunke22 jeunke22 33 minutes ago
Thanks KCC , I am still very positive about my investment here. Doing business implies to understand when it is time to adapt to a given set of circumstances. No need to try to go through a wall, if you can go around it. I think that is what has changed here. A more practical and energetic way to g
LWLG
DMC8 DMC8 37 minutes ago
Feeling burnout recently fellow shareholders?

Watch the youtube chat on how to manage burnout by Patrice Bonfiglio, President of Sarissa Capital Management LP.
https://youtu.be/wpFutxLn-wk?si=6Rm2JhCbHvgvUcsb
AMRN
lodas lodas 38 minutes ago
jhdf51........never buy a Put or a Call option unless you are 100% sure of the outcome at expiration.... why? you only a 50% chance of success... said another way... you either win, or lose...... however by Selling a Put, or Call options, you have a 66% chance of winning, or 2 ways out of three...
COOP
pepeoil pepeoil 41 minutes ago
Good morning shrimpers. Bwahaaaaaa. We are broke. Lol
THEDOG 17 THEDOG 17 46 minutes ago
O and you may as well clock out because Bio was acquired!! Yeah if you can’t figure it out maybe you should read that report eagle just posted!!!! Acquisition!!!!! Let’s gooo
jhdf51 jhdf51 51 minutes ago
My bird in the hand is COOP. Escrow is now a ROC
capable of carrying hopeful escrowers in its talons.

JHD
COOP
jhdf51 jhdf51 55 minutes ago
It seems that people playing options are like people going to Vegas.. they never lose.

JHD
COOP
2018trader 2018trader 56 minutes ago
Just keep buying the monopoly 7, I mean mag 7
SPY
TCI1 TCI1 56 minutes ago
I can’t open the link to the CVS coverage for 2025, would like to see it as they dropped Vascepa in July.

Sleven have you seen any positive or negative changes?
CVS
TCI1 TCI1 58 minutes ago
Well UHC has both IPE and Vascepa covered with PA so you would hope and expect all CVD indications to go to Vascepa. Not sure if this is a change or not but by using a PA UHC are exposing themselves to litigation if they prioritise generic for CVD. Of course this is based off insurers adhering to th
AMRN
Real McCoy Real McCoy 60 minutes ago
Yes. In this case the assets were acquired. A long time ago. Right?
THEDOG 17 THEDOG 17 1 hour ago
Sorry I can read !! Obviously you can’t. Acquisition-is that not a real word?
devil dog 96 devil dog 96 1 hour ago
Their O/S has been unchanged since 2021. These guys protect their share structure + they are great at marketing. Can't wait for them to be ready to fire up their next story. She is setup for some silver with how light they have kept her. Heck she has not had an RS since 2009 like 16 years ago and sh
CRSM
newmedman newmedman 1 hour ago
That's the GOP "man date" ;-)
go seek go seek 1 hour ago
Well, in this game one soon learns that the race is not a sprint. At least that’s my experience. We are all puzzled by the price drop since 24 October. We could debate the drop ad infinitum. I don’t understand it, and probably never will. GLTA
ENTA
Viewmont Viewmont 1 hour ago
It looks like we don't read the news or reports anymore.
They've been yelling that they're getting ready to submit it for FDA approval! LOL.
No need to do any DD, just rely on the next guy.

https://x.com/ADHCMANAGEMENT/status/1866858719339823271
https://x.com/ADH
ADHC
north40000 north40000 1 hour ago
Am I correct that all LTCLs and STCLs currently can be used by either spouse to offset any corresponding LTCGs and STCGs accruing in taxable account(s) in any year before death of either spouse?
AMRN
Remember Tomorrow Remember Tomorrow 1 hour ago
I hate it when I get my Schwartz twisted.

RT
XRPUSD
diversified holdings diversified holdings 1 hour ago
Beautiful! $$$$RNVA$$$$ Thanks satter.
RNVA
nowwhat2 nowwhat2 1 hour ago
Crypto Christmas Bazaar🎅🧑‍🎄


https://investorshub.advfn.com/uimage/uploads/2024/12/20/mjqinBTC_121212_19_XRP_45d_10PM_GRINCH_CALVIN.jpg


https://www.youtube.com/watch?v=MnRLk5jQC2M

https://www.youtube.com/watch
BTCUSD
Real McCoy Real McCoy 1 hour ago
Sorry it’s dead due to liquidation more than 6 years ago.

It’s hard to believe you gave up at 4 years only to come back at 6 like there’s a chance.

Your Recent History

TG
GIS
Gilead Sciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads